No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

Kenneth Rockwood

doi:10.1186/s12916-015-0328-1

No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

Kenneth Rockwood

Office of Academic Affairs

Research output: Contribution to journal › Article › peer-review

266 Citations (Scopus)

Original language	English
Article number	78
Journal	BMC Medicine
Volume	13
Issue number	1
DOIs	https://doi.org/10.1186/s12916-015-0328-1
Publication status	Published - Apr 9 2015

ASJC Scopus Subject Areas

General Medicine

Keywords

Ageing
Antihypertensives
Frailty
Hypertension

Access to Document

10.1186/s12916-015-0328-1

Fingerprint

Dive into the research topics of 'No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over'. Together they form a unique fingerprint.

Cite this

Rockwood, K. (2015). No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Medicine, 13(1), Article 78. https://doi.org/10.1186/s12916-015-0328-1

No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. / Rockwood, Kenneth.
In: BMC Medicine, Vol. 13, No. 1, 78, 09.04.2015.

Research output: Contribution to journal › Article › peer-review

Rockwood, K 2015, 'No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over', BMC Medicine, vol. 13, no. 1, 78. https://doi.org/10.1186/s12916-015-0328-1

Rockwood K. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Medicine. 2015 Apr 9;13(1):78. doi: 10.1186/s12916-015-0328-1

Rockwood, Kenneth. / No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people : An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. In: BMC Medicine. 2015 ; Vol. 13, No. 1.

@article{cbfd1ce620754cd0b64458e1b3981cfd,

title = "No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over",

keywords = "Ageing, Antihypertensives, Frailty, Hypertension",

author = "Kenneth Rockwood",

note = "Publisher Copyright: {\textcopyright} Warwick et al.; licensee BioMed Central.",

year = "2015",

month = apr,

day = "9",

doi = "10.1186/s12916-015-0328-1",

language = "English",

volume = "13",

journal = "BMC Medicine",

issn = "1741-7015",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people

T2 - An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

AU - Rockwood, Kenneth

PY - 2015/4/9

Y1 - 2015/4/9

KW - Ageing

KW - Antihypertensives

KW - Frailty

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=84928041055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928041055&partnerID=8YFLogxK

U2 - 10.1186/s12916-015-0328-1

DO - 10.1186/s12916-015-0328-1

M3 - Article

C2 - 25880068

AN - SCOPUS:84928041055

SN - 1741-7015

VL - 13

JO - BMC Medicine

JF - BMC Medicine

IS - 1

M1 - 78

ER -

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this